Trial Profile
A Study to Evaluate the Efficacy of Reduced Intensity Conditioning With Fludarabine and Busulfan for Allogeneic Hematopoietic Cell Transplantation in Elderly or Infirm Patients With Advanced Myeloid Malignancies
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 18 May 2016
Price :
$35
*
At a glance
- Drugs Benzodiazepines (Primary) ; Busulfan (Primary) ; Fludarabine (Primary)
- Indications Acute myeloid leukaemia; Myelodysplastic syndromes; Myeloproliferative disorders
- Focus Therapeutic Use
- 18 May 2016 New trial record